Table 1. Characteristics of IBC patients analyzed for DLX4 expression in tissues.
| Demographic and clinical characteristics | |
|---|---|
| Age, median (range) | 59 (32–82) |
| Sex, n (%) | |
| Female | 28 (96.6) |
| Male | 1 (3.4) |
| Race, n (%) | |
| African-American | 29 (100.0) |
| T Stage, n (%) | |
| pT1 | 2 (6.9) |
| pT2 | 2 (6.9) |
| pT3 | 1 (3.4) |
| pT4 | 24 (82.8) |
| N Stage, n (%) | |
| pNX | 5 (17.2) |
| pN0 | 3 (10.3) |
| pN1 | 6 (20.7) |
| pN2 | 6 (20.7) |
| pN3 | 9 (31.0) |
| Histologic grade*, n (%) | |
| Grade 1 | 1 (3.4) |
| Grade 2 | 6 (20.7) |
| Grade 3 | 22 (75.9) |
| Estrogen receptor, n (%) | |
| Positive | 20 (69.0) |
| Negative | 9 (31.0) |
| Progesterone receptor, n (%) | |
| Positive | 12 (41.4) |
| Negative | 17 (58.6) |
| HER-2, n (%) | |
| Positive | 6 (20.7) |
| Negative | 23 (79.3) |
| Triple negative status, n (%) | |
| Positive | 4 (13.8) |
| Negative | 25 (86.2) |